Bio Sars Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Delhi, Delhi, India, established in 2008.
2008 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Bio Sars Pharma Private Limited

Bio Sars Pharma Private Limited, a struck off private limited company, was established on 07 November 2008 in Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232DL2008PTC184776. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M.

Its leadership includes Mohammed Ali Qadry (Director), Syed Shamoon Kamal (Director), Rafi Khan (Director). It is based at 1680,Roadgran,Lalkuan,Huaz Qazi, Delhi, Delhi, 110006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2008PTC184776

  • Registration Number

    184776

  • Incorporation Date

    07 November 2008

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 17 Year, 6 Months
Company report

Bio Sars Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Bio Sars Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bio Sars Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohammed Ali Qadry Director 07 Nov 2008 Current
Syed Shamoon Kamal Director 07 Nov 2008 Current
Rafi Khan Director 07 Nov 2008 Current
Smita Arora Additional Director 20 Jan 2009 Current
Mohammad Shakeel Director 07 Nov 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bio Sars Pharma.

Enhance accessibility to Bio Sars Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Bio Sars Pharma revenue growth over time
Bio Sars Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bio Sars Pharma?

Unlock access to Bio Sars Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bio Sars Pharma?

Unlock and access historical data on people associated with Bio Sars Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bio Sars Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Sars Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bio Sars Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Smita Arora was appointed as a Additional Director was appointed as a Additional Director on 20 Jan 2009 & has been associated with this company since 17 years 3 months . was documented.

  • Director Appointment

    Mohammed Ali Qadry was appointed as a Director was appointed as a Director on 07 Nov 2008 & has been associated with this company since 17 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Syed Shamoon Kamal was appointed as a Director was appointed as a Director on 07 Nov 2008 & has been associated with this company since 17 years 6 months . was documented.

  • Director Appointment

    Rafi Khan was appointed as a Director was appointed as a Director on 07 Nov 2008 & has been associated with this company since 17 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Mohammad Shakeel was appointed as a Director was appointed as a Director on 07 Nov 2008 & has been associated with this company since 17 years 6 months . was documented.

  • Company Incorporation

    Progress on Bio Sars Pharma Private Limited was registered on 07 Nov 2008 with Roc Delhi & aged 17 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bio Sars Pharma Private Limited?

The CIN of Bio Sars Pharma Private Limited is U24232DL2008PTC184776.

Where is Bio Sars Pharma Private Limited headquartered?

Bio Sars Pharma Private Limited is headquartered at 1680,Roadgran,Lalkuan,Huaz Qazi, Delhi, Delhi, 110006.

When was Bio Sars Pharma Private Limited incorporated?

Bio Sars Pharma Private Limited was incorporated on 07 November 2008.

Who are the current directors of Bio Sars Pharma Private Limited?

The current directors of Bio Sars Pharma Private Limited are

What is the primary industry of Bio Sars Pharma Private Limited?

The primary industry of Bio Sars Pharma Private Limited is Chemicals.

Is Bio Sars Pharma Private Limited a listed company?

Bio Sars Pharma Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available